Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 weeks agoBeqvez will rival Hemgenix from CSL Behring and Uniqure. Hemgenix gained U.S. approval in late 2022 ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 weeks agoThe company is a leader in the neuroscience space. Neurocrine recently asked the Food and Drug ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
StreetInsider· 2 days agoThe European Union's regulator told vaccine makers last month to update their vaccines for that variant because they would likely be effective against its descendant lineages. The U.S.
The growing promise of cancer vaccines
Cosmos· 23 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 4 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic ...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 2 weeks agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...